Kepler Capital Markets Analysts Give Sartorius (SRT3) a €107.00 Price Target

Share on StockTwits

Kepler Capital Markets set a €107.00 ($124.42) price target on Sartorius (FRA:SRT3) in a research report report published on Thursday, Borsen Zeitung reports. The firm currently has a sell rating on the stock.

SRT3 has been the topic of several other reports. Warburg Research set a €153.50 ($178.49) price objective on shares of Sartorius and gave the stock a neutral rating in a report on Wednesday, February 20th. Deutsche Bank set a €150.00 ($174.42) price objective on shares of Sartorius and gave the stock a neutral rating in a report on Thursday, April 11th. UBS Group set a €147.00 ($170.93) price objective on shares of Sartorius and gave the stock a neutral rating in a report on Thursday. Berenberg Bank set a €110.00 ($127.91) price objective on shares of Sartorius and gave the stock a neutral rating in a report on Tuesday, January 29th. Finally, Hauck & Aufhaeuser set a €130.00 ($151.16) price objective on shares of Sartorius and gave the stock a sell rating in a report on Thursday, April 4th. Five research analysts have rated the stock with a sell rating and four have issued a hold rating to the company. The company currently has an average rating of Sell and a consensus target price of €122.89 ($142.89).

FRA:SRT3 opened at €152.90 ($177.79) on Thursday. Sartorius has a 1-year low of €71.00 ($82.56) and a 1-year high of €124.70 ($145.00).

Sartorius Company Profile

Sartorius Aktiengesellschaft supplies pharmaceutical and laboratory equipment worldwide. It operates in two divisions, Bioprocess Solutions, and Lab Products & Services. The company offers products for suspension cell analysis and live-cell analysis inside incubator for oncology, immuno-oncology, antibody discovery, neuroscience, and stem cell research; cell culture media, including antibody and recombinant protein, viral vaccines, and regenerative medicine media, as well as general media and downstream buffers; and multi-parallel, single-use, benchtop, stainless steel, microbial, and cell culture bioreactors, as well as cell culture expansion systems and software applications for bioreactors.

Recommended Story: What is Depreciation?

Analyst Recommendations for Sartorius (FRA:SRT3)

Receive News & Ratings for Sartorius Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sartorius and related companies with MarketBeat.com's FREE daily email newsletter.